COVID-19,

Sara Ahmadi Badi1,2, Arian Kariman3, Ahmad Bereimipour4

  • 1Biochemistry Department, Pasteur Institute of Iran, Tehran, Iran. sarahmadi@gmail.com.

PubMed
概括

这项研究揭示了COVID-19患者的关键肠道细菌变化,将Akkermansia muciniphila和Escherichia coli等特定微生物与免疫反应和潜在的治疗点联系起来.